Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma

被引:22
作者
Meng, Xin-Jun [1 ,5 ]
Ao, Hua-Fei [2 ]
Huang, Wei-Ting [1 ]
Chen, Fu [3 ]
Sun, Xi-Cai [1 ]
Wang, Jing-Jing [1 ]
Liu, Zhuo-Fu [1 ]
Han, Wade W. [4 ]
Fry, Allison N. [4 ]
Wang, De-Hui [1 ]
机构
[1] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200031, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 3, Dept Otolaryngol, Shanghai 201900, Peoples R China
[3] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Radiat Oncol, Shanghai 200031, Peoples R China
[4] Florida Ear Nose Throat & Facial Plast Surg, Orlando, FL 32819 USA
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Otolaryngol, Shanghai 200025, Peoples R China
来源
BMC CANCER | 2014年 / 14卷
关键词
Sinonasal; Melanoma; Prognosis; Endoscopic sinonasal surgery; Radiotherapy; Chemotherapy; PRIMARY MUCOSAL MELANOMA; PARANASAL SINUSES; CANCER CENTER; NASAL CAVITY; NECK; HEAD; EXPERIENCE; RADIOTHERAPY; OUTCOMES; SURGERY;
D O I
10.1186/1471-2407-14-608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The role of postoperative adjuvant treatment for sinonasal malignant melanoma remains unclear. This study evaluates the impact of three different surgical and postoperative adjuvant treatment modalities: surgery alone(open and endoscopic approaches), surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy on survival of patients with primary sinonasal malignant melanoma (SMM). Methods: The data of 69 patients who underwent primary surgical treatments at Eye & ENT hospital of Fudan University between January 1st, 2000 and December 31st, 2010 were retrospectively reviewed. Survival comparison of different surgical and postoperative adjuvant treatment modalities (surgery alone, surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy), as well as survival comparison between open and endoscopic surgical approaches were performed. Curves depicting survival were performed using Kaplan-Meier method. Statistical analysis was performed using log-rank test software SPSS19 and p < .05 is considered as statistically significant. Results: The median overall survival time was found to be 18 months for surgery alone (27 cases), 32 months for surgery plus radiotherapy (24 cases), 42 months for surgery, radiotherapy plus chemotherapy (18 cases). The 3 and 5 year survival rates for groups mentioned above were 14.8% and 5.6%, 45.1% and 31.6%, 55% and 32.1%, respectively. Statistical significances were found not only between surgery alone and surgery plus radiotherapy treatment group (P = 0.012), but also surgery alone and surgery, radiotherapy plus chemotherapy group (P = 0.002). There was no statistically significant survival difference found between the two different surgical approaches (41 cases for open approach and 28 cases for endoscopic approach). Conclusions: Sinonasal malignant melanoma is a disease with a poor prognosis. Patients who underwent surgery plus radiotherapy or surgery, radiotherapy plus chemotherapy had better survival outcomes than those underwent surgery alone. Endoscopic approach provided similar survival outcome as an open approach.
引用
收藏
页数:9
相关论文
共 27 条
  • [11] Primary mucosal melanoma of the nasal cavity and paranasal sinuses: 12 years of experience
    Huang, Shlang-Fu
    Liao, Chun-Ta
    Kan, Chun-Ran
    Chen, I-How
    [J]. JOURNAL OF OTOLARYNGOLOGY, 2007, 36 (02) : 124 - 129
  • [12] Jangard M, 2013, RHINOLOGY, V51, P22, DOI [10.4193/Rhino12.075, 10.4193/Rhin12.075]
  • [13] Mucosal melanoma of the head and neck
    Kanetaka, Sayaka
    Tsukuda, Mamoru
    Takahashi, Masahiro
    Komatsu, Masanori
    Niho, Tatsuo
    Horiuchi, Choichi
    Matsuda, Hideki
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 907 - 910
  • [14] MUCOSAL MELANOMA OF THE NASAL CAVITY AND PARANASAL SINUSES
    KINGDOM, TT
    KAPLAN, MJ
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (03): : 184 - 189
  • [15] Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma
    Koivunen, Petri
    Back, Leif
    Pukkila, Matti
    Laranne, Jussi
    Kinnunen, Ilpo
    Grenman, Reidar
    Makitie, Antti A.
    [J]. LARYNGOSCOPE, 2012, 122 (08) : 1734 - 1738
  • [16] Lund V, 2011, RHINOLOGY, P1
  • [17] Lund VJ, 2012, RHINOLOGY, V50, P203, DOI [10.4193/Rhin11.267, 10.4193/Rhino.11.267]
  • [18] Management options and survival in malignant melanoma of the sinonasal mucosa
    Lund, VJ
    Howard, DJ
    Harding, L
    Wei, WI
    [J]. LARYNGOSCOPE, 1999, 109 (02) : 208 - 211
  • [19] Mucosal Melanoma of the Nose and Paranasal Sinuses, a Contemporary Experience From The M. D. Anderson Cancer Center
    Moreno, Mauricio A.
    Roberts, Dianna B.
    Kupferman, Michael E.
    DeMonte, Franco
    El-Naggar, Adel K.
    Williams, Michelle
    Rosenthal, David S.
    Hanna, Ehab Y.
    [J]. CANCER, 2010, 116 (09) : 2215 - 2223
  • [20] Sinonasal Mucosal Melanoma: A 13-Year Experience at a Single Institution
    Narasimhan, Kailash
    Kucuk, Omer
    Lin, Ho-Sheng
    Heilbrun, Lance K.
    Carron, Michael
    Venkatramanamoorthy, Raghu
    Mathog, Robert
    [J]. SKULL BASE-AN INTERDISCIPLINARY APPROACH, 2009, 19 (04): : 255 - 262